Skip to main content

Position statements

Cancer Australia position statements address significant clinical issues, emerging issues in cancer control and issues of ongoing interest using the best available evidence.
  • Complementary and alternative therapies

    Revised & updated:
    First published:
    Resource status: Current

    This resource has been developed, reviewed or revised within the last 5 years.

    Summary:

    Although there is some looseness in usage of the terms, complementary therapies refer to those therapies that do not replace or preclude conventional medical therapies, whereas alternative therapies are treatment options outside the orthodox range, that may be used in place of conventional treatments.

  • Hormone Replacement Therapy (HRT) and risk of breast cancer

    Revised & updated:
    First published:
    Resource status: Greater than 5 years

    This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.

    Summary:

    This position statement applies only to Hormone Replacement Therapy (HRT) and breast cancer risk in women – it does not address other risks or benefits to women from HRT usage.

  • Statement on use of thermography to detect breast cancer

    Revised & updated:
    First published:
    Resource status: Greater than 5 years

    This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.

    Summary:

    Cancer Australia does not recommend the use of thermography for the early detection of breast cancer.

  • Surveillance of women at high or potentially high risk of ovarian cancer

    Published:
    Resource status: Greater than 5 years

    This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.

    Summary:

    Familial clusters of ovarian cancer have been recognised for many years and family history has been identified as a risk factor in epidemiological studies that have investigated its role.

  • Early detection of breast cancer

    Revised & updated: ,
    First published:
    Resource status: Current

    This resource has been developed, reviewed or revised within the last 5 years.

    Summary:

    This position statement applies to the early detection of breast cancer in asymptomatic women (women without breast changes). The statement does not apply to diagnostic tests used to assess individual women presenting with breast changes.

  • Population screening and early detection of ovarian cancer in asymptomatic women

    Published:
    Resource status: Greater than 5 years

    This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.

    Summary:

    This position statement and supporting background information has been endorsed by the following colleges and agencies: the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, the Royal Australian College of General Practitioners, the Australian Society Gynaecologic Oncologists, Cancer Council Australia, the Screening Subcommittee of the Department of Health and Ageing, and The Royal College of Pathologists of Australasia.

Pages